(Q39330681)

11 September 2017

title

Combined analysis of smoking, TP53, and FGFR3 mutations in Tunisian patients with invasive and superficial high-grade bladder tumors (English)

1 reference

11 September 2017

Slah Ouerhani

1

1 reference

11 September 2017

Kamel Rouissi

2

1 reference

11 September 2017

Nadia Kourda

3

1 reference

11 September 2017

Raja Marrakchi

4

1 reference

11 September 2017

Karim Bougatef

5

1 reference

11 September 2017

Mohamed Riadh Ben Slama

6

1 reference

11 September 2017

Mohamed Sfaxi

7

1 reference

11 September 2017

Mohamed Chebil

8

1 reference

11 September 2017

Sarra Ben Jilani

9

1 reference

11 September 2017

Amel Benammar Elgaaied

10

1 reference

11 September 2017

publication date

1 December 2009

1 reference

11 September 2017

1 reference

11 September 2017

volume

27

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

998-1007

1 reference

11 September 2017

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Identification of p53 gene mutations in bladder cancers and urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

p53 mutations in urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Genotoxic and non-genotoxic pathways of p53 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

P53 alterations in bladder tumors from arsenic and tobacco exposed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

FGFR activation in skeletal disorders: too much of a good thing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

Cigarette smoking and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

FGFR3 and Tp53 Mutations in T1G3 Transitional Bladder Carcinomas: Independent Distribution and Lack of Association with Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900902849707

10.3109/07357900902849707

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference